A Message from Deal Maker This company is known for its autonomous robotic surgical systems, that completed a crowd funded public offering and NASDAQ Listing. What’s next? They just filed for FDA approval to market and commercialize their patented AI joint replacement tech. By the year 2027, 50% of knee replacement surgeries will be robotic – up from 12% today. Now they’ve opened a unique opportunity for investors. They are selling preferred shares in their company. This isn’t the same stock trading on the Nasdaq. These shares pay an 8% dividend yield (in cash or kind) every year. When Warren Buffett invested $10b in Occidental Petroleum, he didn’t buy the publicly traded stock. He got preferred stock paying an 8% dividend. While you won’t be investing alongside Warren Buffett, they currently offering: - Dividends: The preferred shares pay an 8% annual dividend (in cash or kind)
- Liquidation Preference: Preferred shareholders are entitled to earlier payment than common shareholders
- Conversion: Preferred shares can be converted 1:1 into common shares
- Redemption: They can buy back preferred shares at a premium
- Warrants: Each preferred share comes with one warrant for future shares of common stock at a fixed price
Public shares closed as high as $3.11 within the past month, but the unlisted preferred stock (which is convertible into one share of common) is available for $2.25 per share. This company currently plans to close the Series D Preferred offering on September 12, 2024. - Learn more on their website. | 
No comments:
Post a Comment